回复：亨德里克·范·波佩尔、路易吉·达·波佐、沃尔特·阿尔布雷希特等。一项前瞻性、随机的欧洲癌症研究与治疗组织（EORTC）多组3期研究，比较选择性保留肾单位手术与根治性肾切除术治疗低分期肾细胞癌的肿瘤学结局。《欧洲泌尿外科杂志》2011年；59卷：543 - 52页 - Suppr | 超能文献

Re: Hendrik van Poppel, Luigi da Pozzo, Walter Albrecht, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.

作者信息

Ganesamoni Raguram, Mavuduru Ravimohan, Agarwal Mayank Mohan

出版信息

Eur Urol. 2011 Aug;60(2):e9; author reply e10. doi: 10.1016/j.eururo.2011.05.009. Epub 2011 May 17.

DOI:10.1016/j.eururo.2011.05.009

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Re: Hendrik van Poppel, Luigi da Pozzo, Walter Albrecht, et al. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.回复：亨德里克·范·波佩尔、路易吉·达·波佐、沃尔特·阿尔布雷希特等。一项前瞻性、随机的欧洲癌症研究与治疗组织（EORTC）多组3期研究，比较选择性保留肾单位手术与根治性肾切除术治疗低分期肾细胞癌的肿瘤学结局。《欧洲泌尿外科杂志》2011年；59卷：543 - 52页

Eur Urol. 2011 Aug;60(2):e9; author reply e10. doi: 10.1016/j.eururo.2011.05.009. Epub 2011 May 17.

2

Re: Hendrik Van Poppel, Luigi Da Pozzo, Walter Albrecht, et al. A prospective, randomized EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma. Eur Urol 2011;59:543-52.

Eur Urol. 2012 Apr;61(4):e37-8. doi: 10.1016/j.eururo.2011.11.048. Epub 2011 Dec 7.

3

Re.: A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.关于：一项前瞻性、随机的欧洲癌症研究与治疗组织（EORTC）组间3期研究，比较选择性保留肾单位手术与根治性肾切除术治疗低分期肾细胞癌的肿瘤学结局。

J Urol. 2011 May;185(5):1637-8. doi: 10.1016/j.juro.2011.01.061. Epub 2011 Mar 21.

4

A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.一项前瞻性、随机、EORTC 多组间 3 期研究比较了选择性保留肾单位手术和根治性肾切除术治疗低分期肾细胞癌的肿瘤学结局。

Eur Urol. 2011 Apr;59(4):543-52. doi: 10.1016/j.eururo.2010.12.013. Epub 2010 Dec 22.

5

Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma.择期保留肾单位手术与根治性肾切除术相比仅降低特定肾细胞癌患者亚组的其他原因死亡率。

J Urol. 2016 Oct;196(4):1008-13. doi: 10.1016/j.juro.2016.04.093. Epub 2016 May 25.

6

A prospective randomized EORTC intergroup phase 3 study comparing the complications of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.一项前瞻性随机的欧洲癌症研究与治疗组织（EORTC）组间3期研究，比较选择性保留肾单位手术和根治性肾切除术治疗低分期肾细胞癌的并发症。

Eur Urol. 2007 Jun;51(6):1606-15. doi: 10.1016/j.eururo.2006.11.013. Epub 2006 Nov 15.

7

Perioperative morbidity and renal function in young and elderly patients undergoing elective nephron-sparing surgery or radical nephrectomy for renal tumours larger than 4 cm.接受保留肾单位手术或根治性肾切除术治疗大于 4cm 肾肿瘤的老年和年轻患者的围手术期发病率和肾功能。

BJU Int. 2011 Feb;107(4):554-61. doi: 10.1111/j.1464-410X.2010.09516.x. Epub 2010 Aug 12.

8

Nephron-sparing surgery versus radical nephrectomy for kidney tumors: benefits and limitations.肾肿瘤的保留肾单位手术与根治性肾切除术：益处与局限性

Expert Rev Anticancer Ther. 2011 Jun;11(6):805-8. doi: 10.1586/era.11.66.

9

Nephron-sparing surgery for renal cell carcinoma.肾细胞癌的保留肾单位手术

Annu Rev Med. 2002;53:393-407. doi: 10.1146/annurev.med.53.082901.103937.

10

Can emerging level 1 evidence "discourage" elective nephron-sparing surgery for small renal tumors?新出现的一级证据会“阻碍”对小肾肿瘤进行选择性保留肾单位手术吗？

Eur Urol. 2011 Apr;59(4):553-5. doi: 10.1016/j.eururo.2010.12.041. Epub 2011 Jan 14.

引用本文的文献

1

Partial nephrectomy versus radical nephrectomy for clinical localised renal masses.临床局限性肾肿块的部分肾切除术与根治性肾切除术对比

Cochrane Database Syst Rev. 2017 May 9;5(5):CD012045. doi: 10.1002/14651858.CD012045.pub2.